Randomised phase II trial to investigate catumaxomab (anti-EpCAM x anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

Knodler, M; Korfer, J; Kunzmann, V; Trojan, J; Daum, S; Schenk, M; Kullmann, F; Schroll, S; Behringer, D; Stahl, M; Al-Batran, SE; Hacker, U; Ibach, S; Lindhofer, H; Lordick, F

Knodler, M (reprint author), Univ Hosp Leipzig, UCCL, Leipzig, Germany.

BRITISH JOURNAL OF CANCER, 2018; 119 (3): 296

Abstract

BACKGROUND: Peritoneal carcinomatosis (PC) represents an unfavourable prognostic factor for patients with gastric cancer (GC). Intraperitoneal treatme......

Full Text Link